Science and Technology Committee (Commons)

Regenerative medicine inquiry

Inquiry status: Concluded

Report published. Awaiting a Government response.

Report published

The Science and Technology Committee warns that the NHS’s Personalised Medicine strategy should explicitly support regenerative medicine, and urges government to align its approach on regenerative medicine to the results of its 'Accelerated Access Review’ and to the Industrial Strategy.

Regenerative medicine has enormous potential, offering new stem-cell and other treatments which are significantly improving patients' lives.

The Committee found that despite progress being made in research and development of regenerative medicine therapies, more needs to be done to build on the successes.

The Committee's report, highlights progress to date in taking forward recommendations set out by the Regenerative Medicine Expert Group.

The MPs looked into two key areas: research and commercialisation, and the adoption of regenerative medicine in the NHS. The report suggests that in order for regenerative medicine to continue to develop, it needs a strong foundation of basic scientific research.

Terms of reference: Regenerative medicine

Publications

Read all transcripts, written evidence and other material related to the Regenerative medicine inquiry.

Receive RSS updates

Share this page